Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens (Sigma Pharmaceuticals Plc) |
| Virtual Medicinal Product | Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices |
| Name | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens |
| Abbreviated name | NovoMix 30 FlexPen 100units/ml inj 3ml pre-filled pens |
| Date of name applicability | 27 Feb 2020 |
| Previous name | NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pen |
| Supplier | Sigma Pharmaceuticals Plc |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✓ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens (Sigma Pharmaceuticals Plc) 5 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.